Paper25771069
Efficacy of folic acid therapy in primary prevention of stroke among adults with hypertension in China: the CSPPT randomized clinical trial.
Huo Y and 31 others. JAMA, 2015. Cited by 588 papers, by iCite.
Cite this record
ConductScience Library. Efficacy of folic acid therapy in primary prevention of stroke among adults with hypertension in China: the CSPPT randomized clinical trial. Papers, record 25771069. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/25771069
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antihypertensive Agents | Major topic |
| Enalapril | Major topic |
| Folic Acid | Major topic |
| Hypertension | Major topic |
| Stroke | Major topic |
| Vitamin B Complex | Major topic |
| China | |
| Double-Blind Method | |
| Drug Therapy, Combination | |
| Humans | |
| Kaplan-Meier Estimate | |
| Male | |
| Methylenetetrahydrofolate Reductase (NADPH2) | |
| Middle Aged | |
| Polymorphism, Genetic | |
| Primary Prevention | |
| Risk |
Source PubMed
Grants5
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R21 AI079872 | NIAID NIH HHS | United States | R21AI079872 | PubMed and NIH | NIH RePORTER |
| R21 ES011666 | NIEHS NIH HHS | United States | R21ES011666 | PubMed and NIH | NIH RePORTER |
| R21 HD066471 | NICHD NIH HHS | United States | R21HD066471 | PubMed and NIH | NIH RePORTER |
| U01 AI090727 | NIAID NIH HHS | United States | U01AI090727 | PubMed and NIH | NIH RePORTER |
| R01HD086013 | NIH | NIH RePORTER |
Trials7
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record | Source |
|---|---|---|---|---|
| NCT00794885 | China Stroke Primary Prevention Trial | Derived from the trial | Yes | ClinicalTrials.gov |
| NCT02817503 | Feasibility Study of the Intensive Systolic Blood Pressure Control | Background | ClinicalTrials.gov | |
| NCT03472508 | H-Type Hypertension Precision Medicine Trial | Results | ClinicalTrials.gov | |
| NCT04974138 | China Stroke Primary Prevention Trial 2 for Participants With H-type Hypertension and MTHFR 677 CC/CT Genotype (CSPPT2-CC/CT) | Results | ClinicalTrials.gov | |
| NCT04974151 | China Stroke Primary Prevention Trial 2 for Participants With Hypertension and MTHFR 677 TT Genotype | Results | ClinicalTrials.gov | |
| NCT05169021 | Folic Acid and Intensive Antihypertensive Therapy for Hypertension With CSVD | Results | ClinicalTrials.gov | |
| NCT07680595 | Prospective Management of Plaque Instability With Statins and Extra Folic Acid | Results | ClinicalTrials.gov |
Comments and corrections5
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers | Source |
|---|---|---|---|---|
| Comment in | 25770867 | Folate supplements for stroke prevention: targeted trial trumps the rest. | https://conductscience.org/library/papers/25770867 | PubMed |
| Comment in | 25778787 | Folic acid significantly reduces risk of first stroke, large Chinese study finds. | https://conductscience.org/library/papers/25778787 | PubMed |
| Comment in | 25824518 | Hypertension. Folic acid reduces stroke risk. | https://conductscience.org/library/papers/25824518 | PubMed |
| Comment in | 26187470 | Folic Acid for Stroke Prevention: Time to Revisit Vitamin Therapy in Patients With Kidney Disease? | https://conductscience.org/library/papers/26187470 | PubMed |
| Comment in | 26192588 | ACP Journal Club. In Chinese adults with hypertension, adding folic acid to enalapril reduced incident stroke. | https://conductscience.org/library/papers/26192588 | PubMed |
Cited by375
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 588 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42884618 | The Proposed Vitamin D-Homocysteine Relationship in Cardiometabolic Health: A Narrative Review of Mechanisms, Evidence, and Research Phenotypes. | Nutrients | 2026 | https://conductscience.org/library/papers/42884618 | PubMed |
| 42760941 | MTHFR C677T TT genotype associated with poor blood pressure control in H-type hypertension without folic acid: a retrospective cohort study. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42760941 | PubMed |
| 42739064 | Unmetabolized Folic Acid: Biology, Epidemiology, and Clinical Consequences: A Systematic Review. | Nutrients | 2026 | https://conductscience.org/library/papers/42739064 | PubMed |
| 42580670 | Development of a Prognostic Model for MACE in Atherosclerosis Based on MTHFR and Serum Markers. | Clin Appl Thromb Hemost | 2026 | https://conductscience.org/library/papers/42580670 | PubMed |
| 42540469 | Annexin A1 as a diagnostic biomarker for cyclic Cushing disease. | iScience | 2026 | https://conductscience.org/library/papers/42540469 | PubMed |
| 42489966 | Micronutrients and omega-3 PUFAs to promote healthy ageing: informing a physiology-based complementation strategy. | Geroscience | 2026 | https://conductscience.org/library/papers/42489966 | PubMed |
| 42470822 | Recent advances in methotrexate pharmacology and potential therapeutic uses in age-related cardiometabolic and neurodegenerative diseases. | Pharmacol Rev | 2026 | https://conductscience.org/library/papers/42470822 | PubMed |
| 42430052 | Hyperhomocysteinemia, a risk factor for various health conditions: an umbrella review of systematic reviews with meta-analysis. | Aging Clin Exp Res | 2026 | https://conductscience.org/library/papers/42430052 | PubMed |
| 42410840 | Impact of folic acid supplementation on cardiovascular risk among individuals with hemorrhagic stroke: A prospective study. | Medicine (Baltimore) | 2026 | https://conductscience.org/library/papers/42410840 | PubMed |
| 42395085 | Intake of B vitamins and their circulating levels in relation to incident stroke in women and men: Findings from two national prospective cohorts in the United States. | Am J Prev Cardiol | 2026 | https://conductscience.org/library/papers/42395085 | PubMed |
| 42346130 | Astrocytic Redox Homeostasis as a Metabolic Modulator of DNA Damage and Repair in the Ischemic Penumbra. | Cells | 2026 | https://conductscience.org/library/papers/42346130 | PubMed |
| 42251786 | Fenofibrate attenuates hyperhomocysteinemia-potentiated thrombosis by restoring platelet fatty acid β-oxidation. | Redox Biol | 2026 | https://conductscience.org/library/papers/42251786 | PubMed |
| 42209710 | Lifestyle profiles and long-term blood pressure control are associated with lower risks of stroke and all-cause mortality among treated hypertensive patients: findings from the China Stroke Primary Prevention Trial. | J Hum Hypertens | 2026 | https://conductscience.org/library/papers/42209710 | PubMed |
| 42100908 | Folate and global health review series, part 3: syntheses on cardiovascular, cerebrovascular, and metabolic diseases. | J Glob Health | 2026 | https://conductscience.org/library/papers/42100908 | PubMed |
| 42067935 | B vitamins and cardiovascular health: mechanisms, clinical evidence, and precision prevention strategies. | Nutr Metab (Lond) | 2026 | https://conductscience.org/library/papers/42067935 | PubMed |
| 42057125 | Inflammaging and the role of micronutrients as immunomodulators: a pathway to healthy aging. | Immun Ageing | 2026 | https://conductscience.org/library/papers/42057125 | PubMed |
| 42015255 | Serine Hydroxymethyltransferase (SHMT) in biology and disease: molecular mechanisms and therapeutic targeting. | J Transl Med | 2026 | https://conductscience.org/library/papers/42015255 | PubMed |
| 41917692 | The Neutrophil Percentage-to-Albumin Ratio: An Emerging Biomarker Associated With Primary Stroke Risk in Hypertensive Patients. | J Clin Hypertens (Greenwich) | 2026 | https://conductscience.org/library/papers/41917692 | PubMed |
| 41890215 | One-carbon metabolism and cardiovascular disease: Molecular mechanisms, genetic influences, and epigenetic regulation. | Biochem Biophys Rep | 2026 | https://conductscience.org/library/papers/41890215 | PubMed |
| 41830012 | Complex Effects of B-Vitamin Combinations on Cardiovascular Diseases: A Systematic Review and Meta-Analysis of Randomized Controlled Trials over Three Decades. | Nutrients | 2026 | https://conductscience.org/library/papers/41830012 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| MTHFR | 4524 | PubTator's text mining | https://conductscience.org/library/genes/4524 |
Source NCBI Gene
Drugs4
The drugs whose trials, in the Pipelines release, list the paper.
| Drug | ChEMBL ID | The trials list it as | Trials | In Drugs and targets | Source |
|---|---|---|---|---|---|
| LEVOMEFOLIC ACID | CHEMBL1231574 | Results | 1 | https://conductscience.org/library/drugs/CHEMBL1231574 | ChEMBL |
| AMLODIPINE | CHEMBL1491 | Results | 3 | https://conductscience.org/library/drugs/CHEMBL1491 | ChEMBL |
| FOLIC ACID | CHEMBL1622 | Results | 2 | https://conductscience.org/library/drugs/CHEMBL1622 | ChEMBL |
| ENALAPRIL | CHEMBL578 | Results | 2 | https://conductscience.org/library/drugs/CHEMBL578 | ChEMBL |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- References
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/25771069
GET https://conductscience.org/api/papers/v1/25771069/authors?page=2